292 related articles for article (PubMed ID: 9635538)
21. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry.
Krol AD; le Cessie S; Snijder S; Kluin-Nelemans JC; Kluin PM; Noordijk EM
Ann Oncol; 2003 Jan; 14(1):131-9. PubMed ID: 12488305
[TBL] [Abstract][Full Text] [Related]
22. Applicability of international prognostic index in non Hodgkin's lymphoma in Pakistan.
Aziz Z; Sana S; Saeed S; Akram M
J Ayub Med Coll Abbottabad; 2004; 16(2):15-20. PubMed ID: 15455610
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey.
Arican A; Dinçol D; Akbulut H; Onur H; Demirkazik A; Cay F; Içli F
Am J Clin Oncol; 1999 Dec; 22(6):587-92. PubMed ID: 10597743
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphomas: immunologic prognostic studies.
Hadzi-Pecova L; Petrusevska G; Stojanovic A
Prilozi; 2007 Jul; 28(1):39-55. PubMed ID: 17921917
[TBL] [Abstract][Full Text] [Related]
26. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trials.
Bouabdallah R; Stoppa AM; Coso D; Bardou VJ; Blaise D; Chabannon C; Gastaut JA; Maraninchi D
Ann Oncol; 2001 Apr; 12(4):513-7. PubMed ID: 11398886
[TBL] [Abstract][Full Text] [Related]
28. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
[TBL] [Abstract][Full Text] [Related]
29. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N
Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in non-Hodgkin's lymphoma of Waldeyer's ring and the lymph nodes of the neck].
Kobayashi Y; Ogino T; Hayashi T; Nonaka S; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 2000 Jun; 103(6):761-9. PubMed ID: 10897589
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
[TBL] [Abstract][Full Text] [Related]
32. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
33. [Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases].
Zhang C; Wang XP; Ying ZT; Zheng W; Xie Y; Lin NJ; Ping LY; Liu WP; Deng LJ; Song YQ; Zhu J
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2209-11. PubMed ID: 24169330
[TBL] [Abstract][Full Text] [Related]
34. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
McMaster ML; Johnson DH; Greer JP; Wolff SN; Hildreth CR; Greco FA; Hainsworth JD
Cancer; 1991 Mar; 67(6):1487-92. PubMed ID: 1705861
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
[TBL] [Abstract][Full Text] [Related]
36. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
Mounier N; Gisselbrecht C; Brière J; Haioun C; Feugier P; Offner F; Recher C; Stamatoullas A; Morschhauser F; Macro M; Thieblemont C; Sonet A; Fabiani B; Reyes F;
J Clin Oncol; 2004 Jul; 22(14):2826-34. PubMed ID: 15254050
[TBL] [Abstract][Full Text] [Related]
38. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
40. Primary extranodal non-Hodgkin's lymphoma in adults: clinicopathological and survival characteristics.
Economopoulos T; Asprou N; Stathakis N; Papageorgiou E; Dervenoulas J; Xanthaki K; Raptis S
Leuk Lymphoma; 1996 Mar; 21(1-2):131-6. PubMed ID: 8907280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
